GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Glenmark Life Sciences Ltd (BOM:543322) » Definitions » Net Margin %

Glenmark Life Sciences (BOM:543322) Net Margin % : 18.80% (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Glenmark Life Sciences Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Glenmark Life Sciences's Net Income for the three months ended in Sep. 2024 was ₹953 Mil. Glenmark Life Sciences's Revenue for the three months ended in Sep. 2024 was ₹5,069 Mil. Therefore, Glenmark Life Sciences's net margin for the quarter that ended in Sep. 2024 was 18.80%.

The historical rank and industry rank for Glenmark Life Sciences's Net Margin % or its related term are showing as below:

BOM:543322' s Net Margin % Range Over the Past 10 Years
Min: 18.89   Med: 21.23   Max: 22.8
Current: 20.11


BOM:543322's Net Margin % is ranked better than
87.74% of 995 companies
in the Drug Manufacturers industry
Industry Median: 3.96 vs BOM:543322: 20.11

Glenmark Life Sciences Net Margin % Historical Data

The historical data trend for Glenmark Life Sciences's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glenmark Life Sciences Net Margin % Chart

Glenmark Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Margin %
Get a 7-Day Free Trial 20.95 18.89 20.06 22.80 21.55

Glenmark Life Sciences Quarterly Data
Mar19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.94 20.73 22.35 18.94 18.80

Competitive Comparison of Glenmark Life Sciences's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Glenmark Life Sciences's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Glenmark Life Sciences's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Glenmark Life Sciences's Net Margin % distribution charts can be found below:

* The bar in red indicates where Glenmark Life Sciences's Net Margin % falls into.



Glenmark Life Sciences Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Glenmark Life Sciences's Net Margin for the fiscal year that ended in Mar. 2024 is calculated as

Net Margin=Net Income (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=4708.88/21847.7
=21.55 %

Glenmark Life Sciences's Net Margin for the quarter that ended in Sep. 2024 is calculated as

Net Margin=Net Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=953.16/5068.79
=18.80 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Glenmark Life Sciences  (BOM:543322) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Glenmark Life Sciences Net Margin % Related Terms

Thank you for viewing the detailed overview of Glenmark Life Sciences's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Glenmark Life Sciences Business Description

Traded in Other Exchanges
Address
470, Cardinal Gracious Road, 4th Floor, OIA House, Andheri (East), Mumbai, MH, IND, 400099
Glenmark Life Sciences Ltd develops, manufactures, and supplies high-quality active pharmaceutical ingredients for cardiovascular disease, central nervous system disease, pain management, and diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas.

Glenmark Life Sciences Headlines

No Headlines